Alabama Medical Cannabis Program Moves From Legal Framework to Limited Retail Access
Alabama’s medical cannabis program has moved beyond legislation and into limited retail operations, but access remains narrower than in many states. The state’s first dispensary opened in Montgomery on June 4, 2026, followed by a second announced opening in Talladega on August 28. Additional locations are expected, although licensing disputes and a limited number of approved sites continue to shape the program.
How Alabama legalized medical cannabis
The legal foundation is the Darren Wesley “Ato” Hall Compassion Act, enacted in 2021 through Senate Bill 46. The law created the Alabama Medical Cannabis Commission (AMCC) and authorized a regulated system for cultivation, processing, transportation, testing and dispensing.
The statute does not legalize recreational marijuana. It establishes a medical-use program for registered patients with specified conditions and states that recreational use is outside the law’s purpose. Medical cannabis in Alabama is also not treated as a conventional prescription: physicians certify or recommend its use under state rules.
Alabama’s policy developed gradually. Carly’s Law, enacted in 2014, allowed limited CBD access for certain patients with seizure disorders. A state Medical Cannabis Study Commission followed in 2019, helping lay the groundwork for the broader program approved two years later.
Where the program stands in 2026
Implementation was delayed for years by litigation over the AMCC’s licensing process, including challenges involving application scoring, awards and the Commission’s authority to proceed. Those disputes have not disappeared, but the program has begun serving patients.
As of August 30, 2026, the AMCC has announced dispensary sites in Athens, Attalla, Bessemer, Birmingham, Daphne, Mobile, Montgomery, Oxford and Talladega. The Commission’s patient information page lists Callie’s Apothecary in Montgomery as opening on June 4 and its Talladega location as opening on August 28. The agency says other sites may open as licensees complete the remaining requirements.
The current retail footprint is still developing. One dispensary license awarded in December 2025 remains stayed, while administrative hearings continue in the integrated-facility category. Alabama law allows up to five integrated-facility licenses, with each licensee permitted to operate as many as five dispensing sites. The number and location of operating dispensaries may therefore change as pending proceedings are resolved.
Who may qualify for a medical cannabis card?
Under the AMCC’s current requirements, an applicant must:
- Be an Alabama resident.
- Be at least 19 years old, unless a parent or legal guardian serves as the registered caregiver.
- Have a qualifying medical condition.
- Receive a recommendation from a registered Alabama certifying physician.
- Complete registration through the AMCC patient registry.
The physician must be approved by both the Alabama Board of Medical Examiners and the AMCC. Certification requires an in-person examination and an established physician-patient relationship; telemedicine may not be used for the certification or recertification itself.
The process begins with the physician. If the doctor determines that the patient has a qualifying condition and recommends medical cannabis, the physician enters the certification into the state registry. The patient can then complete the registration and card application. A caregiver, when required or chosen, must submit a separate application tied to the patient’s record.
The AMCC’s fee schedule lists a $40 registration or renewal fee for a digital card and a $50 fee for a physical card. A physical card carries an additional $10 fee when selected with the application. Patients should confirm current fees and application instructions through the AMCC patient and caregiver registration page.
Qualifying conditions
Alabama recognizes the following conditions and circumstances for medical cannabis certification:
- Autism spectrum disorder
- Cancer-related cachexia, nausea or vomiting, weight loss, or chronic pain
- Crohn’s disease
- Depression
- Epilepsy or another condition causing seizures
- HIV/AIDS-related nausea or weight loss
- Panic disorder
- Parkinson’s disease
- Persistent nausea that has not responded adequately to traditional treatment, excluding pregnancy-related nausea and certain cannabis-related vomiting disorders
- Post-traumatic stress disorder
- Sickle cell anemia
- Spasticity associated with a motor-neuron disease, including ALS
- Spasticity associated with multiple sclerosis or a spinal-cord injury
- A terminal illness
- Tourette’s syndrome
- Chronic or intractable pain for which conventional therapeutic intervention and opiate therapy are contraindicated or ineffective
Having one of these diagnoses does not guarantee approval. The certifying physician must determine that medical cannabis is appropriate, review the patient’s medical history and controlled-substance records, consider prior treatments and discuss potential risks and benefits.
What products are allowed?
Alabama’s program is limited to specific non-smokable forms. The AMCC permits products such as tablets, capsules, tinctures, lozenges, topical gels and creams, suppositories, transdermal patches, nebulizer products and certain inhaler liquids or oils.
Raw plant material, products intended to be smoked or vaped, and food products such as cookies or candies are prohibited. The restrictions distinguish Alabama’s medical program from systems that permit patients to purchase flower or traditional cannabis edibles.
What patients should expect
A valid card does not provide unrestricted access to cannabis. Patients may purchase only through licensed dispensaries or integrated facilities and must follow the dosage, product-form and possession limits established by Alabama law and AMCC rules. Medical cannabis cards are valid only in Alabama, and insurance providers are not required to cover either the products or related costs.
The state’s physician rules also require patients to receive warnings about impairment, possible side effects, drug interactions, dependence, employment consequences and the risks of driving or operating machinery. Federal law continues to classify cannabis as a controlled substance, creating additional complications for patients, employers and healthcare providers.
What comes next
Alabama’s immediate challenge is completing the transition from a legally authorized program to a reliable statewide supply network. The AMCC still has to manage licensing proceedings, laboratory capacity, product availability and the expansion of dispensing sites while maintaining the restrictions written into the Compassion Act.
The future of recreational legalization or broader decriminalization is separate from the medical program and is not authorized by current Alabama law. For now, the central policy question is whether the state can expand dependable access for registered patients while preserving the tightly controlled structure established in 2021.
Patients and physicians should rely on the Alabama Medical Cannabis Commission for current dispensary announcements, registry instructions and program rules. Physicians can review certification requirements through the Alabama Board of Medical Examiners’ medical cannabis guidance.
